Related Experiment Video
Updated: Jul 10, 2026

Evaluation of Caspase Activation to Assess Innate Immune Cell Death
Published on: January 20, 2023
Flavopiridol-induced iNOS downregulation during apoptosis of chronic lymphocytic leukemia cells is caspase-dependent
Christian Billard1, Faouzia Menasria, Claire Quiney
1INSERM U872 (équipe 18), Université Pierre et Marie Curie-Paris 6, Paris, France. cbillard@bhdc.jussieu.fr
Abstract:
We previously reported that flavopiridol-induced apoptosis of B cell chronic lymphocytic leukemia (CLL) patients' cells ex vivo is associated with downregulation of both the inducible nitric oxide (NO) synthase (iNOS) that produces the antiapoptotic molecule NO, and the CDK inhibitor p27kip1 that is thought to block the cell cycle of CLL cells. Here, we show that iNOS downregulation is caspase-dependent and thus can be considered as one of the effector mechanisms of apoptosis, but not a primary triggering event induced by flavopiridol. Furthermore, we also find that this flavone favors the entry into the S and G2 phases of the cell cycle of a subpopulation of the leukemic cells, confirming that flavopiridol might be useful for improving the efficacy of cell cycle-dependent cytostatic agents in the therapy of CLL.
Insights
Flavopiridol induces apoptosis in chronic lymphocytic leukemia (CLL) cells by downregulating inducible nitric oxide synthase (iNOS). This effect is caspase-dependent, suggesting flavopiridol enhances cell cycle-dependent therapies for CLL.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Chronic lymphocytic leukemia (CLL) cells exhibit resistance to apoptosis.
- Flavopiridol has shown potential in inducing apoptosis in CLL cells ex vivo.
- Previous studies linked flavopiridol-induced apoptosis to downregulation of inducible nitric oxide synthase (iNOS) and p27kip1.
Purpose of the Study:
- To elucidate the role of inducible nitric oxide synthase (iNOS) downregulation in flavopiridol-induced apoptosis of CLL cells.
- To determine if iNOS downregulation is a primary event or an effector mechanism in flavopiridol-induced apoptosis.
- To investigate the effect of flavopiridol on the cell cycle of CLL cells and its implications for combination therapy.
Main Methods:
- Ex vivo culture of CLL patient cells.
- Treatment with flavopiridol.
- Assessment of caspase activity.
- Analysis of inducible nitric oxide synthase (iNOS) expression and activity.
- Cell cycle analysis using flow cytometry.
Main Results:
- Flavopiridol-induced downregulation of iNOS is dependent on caspase activation, indicating it is an effector mechanism of apoptosis.
- iNOS downregulation is not the primary triggering event for flavopiridol-induced apoptosis.
- Flavopiridol promotes the entry of a subpopulation of CLL cells into the S and G2 phases of the cell cycle.
Conclusions:
- Flavopiridol-induced iNOS downregulation is a downstream consequence of apoptosis, mediated by caspases.
- Flavopiridol's ability to modulate the cell cycle suggests a potential synergistic effect with cell cycle-dependent therapies in CLL treatment.
- These findings support the investigation of flavopiridol in combination strategies for managing CLL.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Caspases
The Extrinsic Apoptotic Pathway
Apoptosis
Cellular Injury V: Apoptosis and Autophagy
